{"id":"https://openalex.org/W1995170149","doi":"https://doi.org/10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.0.co;2-h","title":"Fluoroazomycin arabinoside (FAZA): synthesis, 2H and 3H\u2010labelling and preliminary biological evaluation of a novel 2\u2010nitroimidazole marker of tissue hypoxia","display_name":"Fluoroazomycin arabinoside (FAZA): synthesis, 2H and 3H\u2010labelling and preliminary biological evaluation of a novel 2\u2010nitroimidazole marker of tissue hypoxia","publication_year":1999,"publication_date":"1999-01-01","ids":{"openalex":"https://openalex.org/W1995170149","doi":"https://doi.org/10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.0.co;2-h","mag":"1995170149"},"language":"en","primary_location":{"id":"doi:10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.0.co;2-h","doi":"https://doi.org/10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.0.co;2-h","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.0.co;2-h","pdf_url":null,"source":{"id":"https://openalex.org/S90602895","display_name":"Journal of Labelled Compounds and Radiopharmaceuticals","issn_l":"0362-4803","issn":["0362-4803","1099-1344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Labelled Compounds and Radiopharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063709973","display_name":"Piyush Kumar","orcid":"https://orcid.org/0000-0003-3113-3933","observed_orcids":["https://orcid.org/0000-0003-3113-3933"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Kumar","raw_affiliation_strings":["Noujaim Institute for Pharmaceutical Oncology Research, Faculty of Pharmacy and Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Noujaim Institute for Pharmaceutical Oncology Research, Faculty of Pharmacy and Pharmaceutical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035258562","display_name":"Daria Stypinski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Stypinski","raw_affiliation_strings":["Noujaim Institute for Pharmaceutical Oncology Research, Faculty of Pharmacy and Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Noujaim Institute for Pharmaceutical Oncology Research, Faculty of Pharmacy and Pharmaceutical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110191000","display_name":"Hong Jun Xia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Xia","raw_affiliation_strings":["Noujaim Institute for Pharmaceutical Oncology Research, Faculty of Pharmacy and Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Noujaim Institute for Pharmaceutical Oncology Research, Faculty of Pharmacy and Pharmaceutical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112360493","display_name":"Alexander J.B. McEwan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"A. J. B. McEwan","raw_affiliation_strings":["Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada, T6G 2N8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada, T6G 2N8","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111602681","display_name":"HJ Machulla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H-J. Machulla","raw_affiliation_strings":["Eberhardt-Karls-University Hospital, Roentgenweg 15, D-72076 Tuebingen 13, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eberhardt-Karls-University Hospital, Roentgenweg 15, D-72076 Tuebingen 13, FRG","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068886356","display_name":"Leonard Irving Wiebe","orcid":"https://orcid.org/0000-0002-7078-4379","observed_orcids":["https://orcid.org/0000-0002-7078-4379"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"L. I. Wiebe","raw_affiliation_strings":["Noujaim Institute for Pharmaceutical Oncology Research, Faculty of Pharmacy and Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Noujaim Institute for Pharmaceutical Oncology Research, Faculty of Pharmacy and Pharmaceutical Sciences","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5068886356"],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":1.4845,"has_fulltext":false,"cited_by_count":81,"citation_normalized_percentile":{"value":0.80014158,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"42","issue":"1","first_page":"3","last_page":"16"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9667999744415283,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9667999744415283,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.021800000220537186,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/2-nitroimidazole","display_name":"2-nitroimidazole","score":0.9269999861717224},{"id":"https://openalex.org/keywords/tissue-hypoxia","display_name":"tissue hypoxia","score":0.7609999775886536},{"id":"https://openalex.org/keywords/pet-imaging-agents","display_name":"PET imaging agents","score":0.796999990940094},{"id":"https://openalex.org/keywords/fluorination","display_name":"fluorination","score":0.6050000190734863},{"id":"https://openalex.org/keywords/deuterium-labeling","display_name":"deuterium labeling","score":0.8130000233650208},{"id":"https://openalex.org/keywords/tritium-labeling","display_name":"tritium labeling","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fluorine-18-radiolabeling","display_name":"fluorine-18 radiolabeling","score":0.7300000190734863},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.7960000038146973},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9380000233650208}],"concepts":[{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.9074763059616089},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.898408830165863},{"id":"https://openalex.org/C2780523633","wikidata":"https://www.wikidata.org/wiki/Q380709","display_name":"Labelling","level":2,"score":0.7981039881706238},{"id":"https://openalex.org/C2781047020","wikidata":"https://www.wikidata.org/wiki/Q425059","display_name":"Nitroimidazole","level":2,"score":0.749189019203186},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.630888819694519},{"id":"https://openalex.org/C177322064","wikidata":"https://www.wikidata.org/wiki/Q750955","display_name":"Radiochemistry","level":1,"score":0.5887152552604675},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5348066091537476},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.48929354548454285},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4470599591732025},{"id":"https://openalex.org/C3017724952","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Pet imaging","level":3,"score":0.4404962956905365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3273478150367737},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.253446102142334},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.24617356061935425},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.228645920753479},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.22508323192596436},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.12362441420555115},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.09201741218566895},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.0.co;2-h","doi":"https://doi.org/10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.0.co;2-h","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.0.co;2-h","pdf_url":null,"source":{"id":"https://openalex.org/S90602895","display_name":"Journal of Labelled Compounds and Radiopharmaceuticals","issn_l":"0362-4803","issn":["0362-4803","1099-1344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Labelled Compounds and Radiopharmaceuticals","raw_type":"journal-article"},{"id":"doi:10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.3.co;2-8","doi":"https://doi.org/10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.3.co;2-8","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-1344(199901)42:1<3::aid-jlcr160>3.3.co;2-8","pdf_url":null,"source":{"id":"https://openalex.org/S90602895","display_name":"Journal of Labelled Compounds and Radiopharmaceuticals","issn_l":"0362-4803","issn":["0362-4803","1099-1344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Labelled Compounds and Radiopharmaceuticals","raw_type":"journal-article"},{"id":"mag:3010572033","doi":null,"is_oa":false,"landing_page_url":"http://jglobal.jst.go.jp/public/20090422/200902172696173653","pdf_url":null,"source":{"id":"https://openalex.org/S90602895","display_name":"Journal of Labelled Compounds and Radiopharmaceuticals","issn_l":"0362-4803","issn":["0362-4803","1099-1344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Labelled Compounds and Radiopharmaceuticals","raw_type":null},{"id":"mag:3015576588","doi":null,"is_oa":false,"landing_page_url":"https://jglobal.jst.go.jp/detail?JGLOBAL_ID=200902172696173653","pdf_url":null,"source":{"id":"https://openalex.org/S90602895","display_name":"Journal of Labelled Compounds and Radiopharmaceuticals","issn_l":"0362-4803","issn":["0362-4803","1099-1344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Labelled Compounds and Radiopharmaceuticals","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2620069305","https://openalex.org/W1968544846","https://openalex.org/W2482838129","https://openalex.org/W2041258384","https://openalex.org/W1863981014","https://openalex.org/W2018239968","https://openalex.org/W1977493191","https://openalex.org/W2911634249","https://openalex.org/W2136431910","https://openalex.org/W1972529932"],"abstract_inverted_index":{"1-\u03b1-D-(5-Fluoro-5-deoxyarabinofuranosyl)-2-nitroimidazole":[0],"(fluoroazomycin":[1],"arabinoside,":[2],"FAZA)":[3],"6,":[4],"a":[5,65,89],"putative":[6],"PET":[7],"imaging":[8],"agent":[9],"when":[10],"labelled":[11],"with":[12,21],"18F,":[13],"was":[14],"synthesized":[15],"by":[16,24,33,45],"fluorination":[17,47],"of":[18,38,87,94],"1-\u03b1-D-(2,3-di-O-acetylarabinofuranosyl)-2-nitroimidazole":[19],"3":[20],"DAST":[22],"followed":[23,44],"deprotection.":[25],"The":[26],"C-5\u2032-deuterated":[27],"and":[28,48,54,69,81],"tritiated":[29,56],"analogues":[30],"were":[31],"prepared":[32],"NaCNBD3":[34],"or":[35],"NaCNBT3":[36],"reduction":[37],"the":[39],"protected":[40],"C-5\u2032-carbonyl":[41],"intermediate":[42],"5,":[43],"C-5\u2032":[46,52,55],"deprotection,":[49],"to":[50,85],"afford":[51],"deuterated":[53],"FAZA,":[57],"respectively.":[58],"Preliminary":[59],"in":[60,64,72],"vivo":[61],"biodistribution":[62],"studies":[63,71],"murine":[66],"tumour":[67,79],"model,":[68],"pharmacokinetic":[70,82],"rats":[73],"indicated":[74],"that":[75],"3H-FAZA":[76],"has":[77],"biodistribution,":[78],"uptake":[80],"properties":[83],"similar":[84],"those":[86],"123I-IAZA,":[88],"clinically-proven":[90],"radiopharmaceutical":[91],"for":[92],"SPECT-imaging":[93],"hypoxic":[95],"tissues.":[96],"Copyright":[97],"\u00a9":[98],"1999":[99],"John":[100],"Wiley":[101],"&":[102],"Sons,":[103],"Ltd.":[104]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}